Enhanced neuroprotective effect by combination of bromocriptine and Hypericum perforatum extract against MPTP-induced neurotoxicity in mice

Journal of the Neurological Sciences

Volumn 249, Issue 2, 2006, Pages 140-144

  Mohanasundari, M ^a   Srinivasan, M S ^a   Sethupathy, S ^a   Sabesan, M ^a  

^a ANNAMALAI UNIVERSITY   (India)

Author keywords

Antioxidants; Dopamine; Lipid peroxidation; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; BROMOCRIPTINE; DOPAMINE; HYPERICUM PERFORATUM EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOPAMINE BLOOD LEVEL; DRUG INDUCED DISEASE; FOREFOOT; LIPID PEROXIDATION; MALE; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; ROTAROD TEST;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTIPARKINSON AGENTS; ATAXIA; BROMOCRIPTINE; CATALASE; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGONISTS; DRUG EVALUATION, PRECLINICAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HAND STRENGTH; HYPERICUM; LIPID PEROXIDATION; LOCOMOTION; MALE; MICE; MPTP POISONING; MUSCLE WEAKNESS; NEUROPROTECTIVE AGENTS; PARKINSONIAN DISORDERS; PHYTOTHERAPY; PLANT EXTRACTS; SUPEROXIDE DISMUTASE;

EID: 33750503773     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2006.06.018     Document Type: Article

References (29)

1. Langston J.W., Ballard P., Tetrud J.W., and Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219 (1983) 979-980
2. Gerlach M., and Riederer P. Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm 103 (1996) 987-1041
3. +, a metabolite of the neurotoxin MPTP. Life Sci 36 (1985) 2503-2508
4. Li Q.Y., Pedersen C., Day B., and Petal M. Dependence of exitotoxic neurodegeneration on mitochondrial aconitase inactivation. J Neurochem 78 (2001) 746-755
5. Kondo T., Ito F., and Sugita Y. Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann N.Y. Acad Sci 738 (1999) 222-229
6. Ogawa N., Tanaka K., Asanuma M., Kawai M., Masumizu T., Kohno M., et al. Bromocriptine protects mice against 6-hydroxydopamine and scavenges hydroxyl free radicals in vitro. Brain Res 657 (1994) 207-213
7. Muralikrishnan D., and Mohanakumar K.P. Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice. FASEB J 12 (1998) 905-912
8. Calne D.B., Plotkin C., Williams A.C., Nutt J.G., Neophytides A., and Teychenne P.F. Long-term treatment of Parkinsonism with bromocriptine. Lancet 1 8067 (1978) 735-738
9. Hoehn M.M. Result of chronic levodopa therapy and its modification by bromocriptine in Parkinson's disease. Acta Neurol Scand 71 (1985) 97-106
10. Gardner P.T., White T.A.C., Mc Phail D.B., and Duthie G.G. The relative contributions of vitamin C, carotenoids and phenolics to the antioxidant potential of fruit juices. Food Chem 68 (2000) 471-474
11. Silva B.A., Ferreres F., Malva J., and Dias A.C.P. Phytochemical and antioxidant characterization of Hypericum perforatum alcoholic extracts. Food Chem 90 (2005) 157-167
12. El-Sherbiny D.A., Khalifa A.I., Attia A.S., and Ezz Eldenshary E.S. Hypericum perforatum extract demonstrates antioxidant properties against elevated rat brain oxidative status induced by amnestic dose of scopolamine. Pharmacol Biochem Behav 76 (2003) 525-533
13. Tripathy Yamini B., Savitha E., and Anil Upadhyay T. Bacopa monniera linn, as a antioxidant: mechanism of action. Indian J Exp Biol 34 (1996) 523
14. Cervol M., Rozio B., Ekalce-Soppo B., Guiso G., Morazzoni P., and Caccia S. Role of hyperforin in the antidepressant like activity of Hypericum perforatum extracts. Psycho Pharmacol 164 (2002) 423-428
15. Przedborski S., and Vila M. MPTP: a review of its mechanisms of neurotoxicity. Clin Neurosci Res 1 (2001) 407-418
16. Rozas G., Guerra M.J., and Labandeira-Garcia J.L. An automated Rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of Parkinsonism. Brain Res Protoc 2 (1997) 75-84
17. Tillerson J.L., Michael Caudle W., Reverson M.E., and Miller G.W. Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Exp Neurol 178 (2002) 80-90
18. Ben-Shachar D., and Youdim M.B. Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction. J Neural Transm Suppl. 29 (1999) 251-258
19. Beutler E. Cell metabolism. A manual of biochemical methods. 13th edition (1984), Grane and Straton Orlands
20. Kakkar P., Das B., and Viswanathan P.W. Modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21 (1984) 130
21. Sinha A.K. Colometric assay of Catalase. Anal Biochem 47 (1972) 389
22. Rotruck J.T., Pope A.L., Ganthor H.E., and Swanson A.B. Selenium biochemical role as a component of glutathione peroxidase. Science 179 (1973) 588
23. Ohkawa H., Ohishi W., and Yahik K. Assay for lipid peroxidation in animal tissues by thiobarbituric acid reaction. Anal Biochem 95 (1979) 351
24. Lowry O.H., Roseborough N.J., Farr A.L., and Randal R.J. Protein measurement with folin's phenol, reagent. J Biol Chem 193 (1951) 265
25. Duan W., and Mattson M.P. Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. Neurosci Res 57 (1999) 195-206
26. 2 dopamine receptor deficient mice in determined by gene dosage, genetic background and developmental adaptations. Neurosci 18 (1998) 7470-7479
27. Barthwal M.K., Srivastava N., Shukla R., Nag D., Seth P.K., Srimal R.C., et al. Polymorphonuclear leukocyte nitrite content and antioxidant enzymes in Parkinson's disease patients. Acta Neurol Scand 100 (1999) 300-304
28. Felten D.L., Felton S.Y., Fuller R.W., Romano T.D., Smalstig E.B., Wong D.T., et al. Chronic dietary pergolide preserves nigrostriatal neuronal integrity in aged fishers-344 rats. Neurobiol Aging 13 (1992) 339-351
29. Serdarevic N., Eckert G.P., and Muller W.E. The effects of extracts from St. John's Wort and Kava Kava on brain neurotransmitter levels in the mouse. Pharmacopsychiatry 34 (2001) 34-36